In both IBD patients and animal models, an increase in the number of M1 macrophages and a significant elevation in serum levels of pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6, have been observed, with ROS playing a pivotal role as a signaling molecule in triggering and amplifying the inflammatory response. This evidence concerns the gene IL6 and inflammatory bowel disease.